Equillium

EQ · NASDAQ

$1.38+$0.14 (+11.29%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $1.24

Latest news

Press releaseOct 5, 4:05 PM ETGlobe Newswire
Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
Press releaseSep 29, 4:05 PM ETGlobe Newswire
Equillium Announces Poster Presentations at the 7th International AHR Conference
Press releaseMay 20, 4:05 PM ETGlobe Newswire
Equillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis
NewsMay 15, 5:06 PM ET
12 Health Care Stocks Moving In Friday's After-Market Session
Press releaseMar 25, 4:05 PM ETGlobe Newswire
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights
Press releaseOct 22, 8:00 AM ETGlobe Newswire
Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025
NewsSep 5, 1:06 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
Press releaseSep 3, 4:05 PM ETBusiness Wire
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press releaseAug 29, 4:03 PM ETBusiness Wire
Equillium to Participate in the Cantor Global Healthcare Conference 2025
NewsAug 26, 5:08 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
NewsAug 22, 1:06 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsAug 15, 1:07 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsAug 11, 5:06 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsAug 11, 1:06 PM ET
12 Health Care Stocks Moving In Monday's Intraday Session
NewsAug 11, 12:28 PM ETAvi Kapoor
Gold Down Over 2%; Monday.com Shares Tumble After Q2 Results
NewsAug 11, 9:50 AM ETAvi Kapoor
US Stocks Mixed; Owens & Minor Posts Downbeat Earnings
Press releaseAug 11, 8:30 AM ETBusiness Wire
Equillium Announces Up to $50 Million Financing to Advance EQ504, a Novel Aryl Hydrocarbon Receptor Modulator, into the Clinic
NewsAug 4, 1:06 PM ET
12 Health Care Stocks Moving In Monday's Intraday Session
Press releaseAug 4, 8:30 AM ETBusiness Wire
Equillium Announces Strategic Expansion of Cryptocurrency Treasury Reserve Strategy
NewsAug 4, 6:55 AM ETAvi Kapoor
Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
Press releaseMay 6, 8:00 AM ETBusiness Wire
Equillium Announces Multiple Poster Presentations Highlighting EQ504 at the Annual Meeting of The American Association of Immunologists
Press releaseMay 1, 8:00 AM ETBusiness Wire
Equillium Announces New Aryl Hydrocarbon Receptor Modulator Program EQ504
Press releaseApr 24, 9:00 AM ETBusiness Wire
Equillium Announces Feedback from the U.S. Food and Drug Administration
NewsMar 27, 1:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsMar 27, 12:12 PM ETAvi Kapoor
Gold Gains Over 1%; TD SYNNEX Shares Plunge After Downbeat Results
NewsMar 27, 9:51 AM ETAvi Kapoor
Nasdaq Down Over 100 Points; US Initial Jobless Claims Fall
Press releaseMar 27, 7:00 AM ETBusiness Wire
Equillium Announces Results of the Phase 3 EQUATOR Study of Itolizumab in First-Line Treatment of Patients with Acute Graft-Versus-Host Disease
Press releaseMar 27, 7:00 AM ETBusiness Wire
Equillium Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate and Clinical Highlights
Press releaseFeb 6, 8:00 AM ETBusiness Wire
Equillium Announces Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with Moderate to Severe Ulcerative Colitis
Press releaseNov 13, 4:01 PM ETBusiness Wire
Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates
Press releaseNov 13, 8:00 AM ETBusiness Wire
Equillium to Present at the Stifel Healthcare Conference
Press releaseNov 12, 8:00 AM ETBusiness Wire
Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer
NewsOct 31, 8:09 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsOct 31, 8:09 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseOct 31, 7:00 AM ETBusiness Wire
Equillium Maintains Rights to Itolizumab Following Ono Partnership
NewsOct 31, 6:52 AM ETAvi Kapoor
Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Press releaseOct 7, 8:00 AM ETBusiness Wire
Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer
Press releaseAug 8, 4:01 PM ETBusiness Wire
Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504

Equillium Announces Poster Presentations at the 7th International AHR Conference

Equillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis

12 Health Care Stocks Moving In Friday's After-Market Session

Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights

Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025

12 Health Care Stocks Moving In Friday's Intraday Session

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Equillium to Participate in the Cantor Global Healthcare Conference 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Monday's Intraday Session

Gold Down Over 2%; Monday.com Shares Tumble After Q2 Results

US Stocks Mixed; Owens & Minor Posts Downbeat Earnings

Equillium Announces Up to $50 Million Financing to Advance EQ504, a Novel Aryl Hydrocarbon Receptor Modulator, into the Clinic

12 Health Care Stocks Moving In Monday's Intraday Session

Equillium Announces Strategic Expansion of Cryptocurrency Treasury Reserve Strategy

Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket

Equillium Announces Multiple Poster Presentations Highlighting EQ504 at the Annual Meeting of The American Association of Immunologists

Equillium Announces New Aryl Hydrocarbon Receptor Modulator Program EQ504

Equillium Announces Feedback from the U.S. Food and Drug Administration

12 Health Care Stocks Moving In Thursday's Intraday Session

Gold Gains Over 1%; TD SYNNEX Shares Plunge After Downbeat Results

Nasdaq Down Over 100 Points; US Initial Jobless Claims Fall

Equillium Announces Results of the Phase 3 EQUATOR Study of Itolizumab in First-Line Treatment of Patients with Acute Graft-Versus-Host Disease

Equillium Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate and Clinical Highlights

Equillium Announces Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with Moderate to Severe Ulcerative Colitis

Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates

Equillium to Present at the Stifel Healthcare Conference

Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer

12 Health Care Stocks Moving In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Equillium Maintains Rights to Itolizumab Following Ono Partnership

Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer

Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights